miR‐203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver

Liver resection is still the most commonly used therapeutic treatment for hepatocellular carcinoma (HCC), and liver regeneration promotes HCC growth in the regenerating liver. The high recurrence/metastasis of HCC is the main cause of death for HCC patients after liver resection. However, how the au...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiao‐Bo, Chen, Xiao‐Bo, Xu, Liang‐Liang, Zhang, Ming, Feng, Lei, Yi, Peng‐Sheng, Tang, Jian‐Wei, Xu, Ming‐Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378262/
https://www.ncbi.nlm.nih.gov/pubmed/28100026
http://dx.doi.org/10.1111/cas.13167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378262/
https://www.ncbi.nlm.nih.gov/pubmed/28100026
http://dx.doi.org/10.1111/cas.13167

Ejemplares similares